Trial · NCT01404949
Adverse events91
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 91
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nail ridging | Skin and subcutaneous tissue disorders | Tretinoin and Arsenic Trioxide | 2 | 17 | |
| other | Nausea | Gastrointestinal disorders | Tretinoin and Arsenic Trioxide | 2 | 17 | |
| other | Sinus tachycardia | Cardiac disorders | Tretinoin and Arsenic Trioxide | 2 | 17 | |
| other | Skin & subcutaneous tissue disordered Others, spec | Skin and subcutaneous tissue disorders | Tretinoin and Arsenic Trioxide | 2 | 17 | |
| other | Weight loss | Investigations | Tretinoin and Arsenic Trioxide | 2 | 17 | |
| other | Abdominal distension | Gastrointestinal disorders | Tretinoin and Arsenic Trioxide | 1 | 17 | |
| other | Alanine aminotransferase increase | Investigations | Tretinoin and Arsenic Trioxide | 1 | 17 | |
| other | Alopecia | Skin and subcutaneous tissue disorders | Tretinoin and Arsenic Trioxide | 1 | 17 | |
| other | Anorexia | Metabolism and nutrition disorders | Tretinoin and Arsenic Trioxide | 1 | 17 | |
| other | Blood bilirubin increased | Investigations | Tretinoin and Arsenic Trioxide | 1 | 17 | |
| other | Bruising | Injury, poisoning and procedural complications | Tretinoin and Arsenic Trioxide | 1 | 17 | |
| other | Cardiac disorders - Other, specify | Cardiac disorders | Tretinoin and Arsenic Trioxide | 1 | 17 | |
| other | Cataract | Eye disorders | Tretinoin and Arsenic Trioxide | 1 | 17 | |
| other | Cholesterol high | Investigations | Tretinoin and Arsenic Trioxide | 1 | 17 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Tretinoin and Arsenic Trioxide | 1 | 17 | |
| other | Depression | Psychiatric disorders | Tretinoin and Arsenic Trioxide | 1 | 17 | |
| other | Dizziness | Nervous system disorders | Tretinoin and Arsenic Trioxide | 1 | 17 | |
| other | Dry eye | Eye disorders | Tretinoin and Arsenic Trioxide | 1 | 17 | |
| other | Dry mouth | Gastrointestinal disorders | Tretinoin and Arsenic Trioxide | 1 | 17 | |
| other | Dyspnea | Respiratory, thoracic and mediastinal disorders | Tretinoin and Arsenic Trioxide | 1 | 17 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01404949/events?page=2